We are live on ! Find out more
Osaic Holdings

Osaic Holdings Portfolio holdings

AUM $68.3B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+20.5%
3 Year Est. Return
+61.22%
5 Year Est. Return
+69.4%
10 Year Est. Return
AUM
$52.8B
AUM Growth
+$4.84B
Cap. Flow
+$1.8B
Cap. Flow %
3.41%
Top 10 Hldgs %
16.61%
Holding
7,915
New
532
Increased
3,448
Reduced
2,610
Closed
320
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CURO
6626
DELISTED
CURO Group Holdings Corp.
CURO
$5K ﹤0.01%
300
LBC
6627
DELISTED
Luther Burbank Corporation Common Stock
LBC
$5K ﹤0.01%
340
EGGF.U
6628
DELISTED
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
$5K ﹤0.01%
500
CWBR
6629
DELISTED
CohBar, Inc. Common Stock
CWBR
$5K ﹤0.01%
537
-711
-57% -$13.6K
APGB.U
6630
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$5K ﹤0.01%
471
AVTA
6631
DELISTED
Avantax, Inc. Common Stock
AVTA
$5K ﹤0.01%
255
+3
+1% +$51
HCCI
6632
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$5K ﹤0.01%
141
ELYS
6633
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$5K ﹤0.01%
1,935
-975
-34% -$4K
ADER
6634
DELISTED
26 Capital Acquisition Corp
ADER
$5K ﹤0.01%
500
-500
-50% -$4.92K
ADERU
6635
DELISTED
26 Capital Acquisition Corp Unit
ADERU
$5K ﹤0.01%
500
HARP
6636
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$5K ﹤0.01%
+64
New +$4.37K
ARBG
6637
DELISTED
Aequi Acquisition Corp
ARBG
$5K ﹤0.01%
500
EVLO
6638
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$5K ﹤0.01%
+38
New +$6.42K
LITTU
6639
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
$5K ﹤0.01%
500
APTO
6640
DELISTED
Aptose Biosciences, Inc.
APTO
$5K ﹤0.01%
9
+2
+29% +$1.88K
PNTM
6641
DELISTED
Pontem Corporation
PNTM
$5K ﹤0.01%
500
PLXP
6642
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$5K ﹤0.01%
675
-825
-55% -$9.67K
IIGV
6643
DELISTED
Invesco Investment Grade Value ETF
IIGV
$5K ﹤0.01%
184
-544
-75% -$14.8K
TBSA
6644
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
$5K ﹤0.01%
501
FSTX
6645
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$5K ﹤0.01%
1,049
+21
+2% +$127
FPAC
6646
DELISTED
Far Peak Acquisition Corporation
FPAC
$5K ﹤0.01%
+500
New +$5.15K
OIIM
6647
DELISTED
02Micro International
OIIM
$5K ﹤0.01%
1,000
-2,325
-70% -$13.2K
HYRE
6648
DELISTED
HyreCar Inc. Common Stock
HYRE
$5K ﹤0.01%
1,000
JCIC
6649
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
$5K ﹤0.01%
500
OYST
6650
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$5K ﹤0.01%
+250
New +$3.17K

Similar funds

Osaic Holdings's Q4 2021 Portfolio in Review

As of Q4 2021, Osaic Holdings held 7,915 positions worth $52.8B, up 10% from $48B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Osaic Holdings deployed $1.8B of net new capital in Q4 2021, opening 532 new positions and adding to 3,448 existing holdings. Its largest new stake was Rivian: 69,288 shares worth $7.18M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $306M trimmed.

  • Osaic Holdings's largest Q4 2021 buy was Rivian: 69,288 shares worth $7.18M.
  • Osaic Holdings added most to Schwab Fundamental US Large Company Index ETF in Q4 2021, an estimated $175M increase.
  • Osaic Holdings's biggest Q4 2021 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $306M.
  • Osaic Holdings fully exited Invesco BulletShares 2021 Corporate Bond ETF in Q4 2021, selling an estimated $10.9M.
  • Osaic Holdings's ten largest holdings make up 17% of its $52.8B portfolio in Q4 2021.
  • Osaic Holdings opened 532 new positions and closed 320 in Q4 2021.
  • Osaic Holdings's portfolio value rose 10% quarter-over-quarter to $52.8B.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.